Frank Trudo, MD, MBA, was recently appointed as VP, US Respiratory, Medical Affairs, at AstraZeneca.
Results from a 2017 clinical trial indicated that the Accelerate Pheno system produced an ID result in about 1 hour and 24 minutes in 95% of runs.
The Accelerate PhenoTM system allows for pathogen identification in only 90 minutes, and is revolutionizing infectious disease diagnostics.
One study has shown that 90-day prescriptions can increase adherence over 30-day prescriptions.
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.